The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis

TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis

June 3, 2013 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

New research elucidates the role of tumor necrosis factor (TNF)–α in immune regulation in patients with rheumatoid arthritis (RA). Hong Nie, MD, PhD, of the Shanghai Jiao Tong University School of Medicine in China, and colleagues examined the synovium of patients with RA in order to better understand the relationship between regulatory T (Treg) cells and pathogenic T cells. The results were published in Nature Medicine.1

You Might Also Like
  • Adalimumab Drives Regulatory T Cell Expansion by Binding to Membrane TNF
  • 2014 ACR/ARHP Annual Meeting: Regulatory T Cells
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
Also By This Author
  • Antiphospholipid Antibody Syndrome: Much Remains to be Learned

Previous studies have noted that the number/percentage of Treg cells does not differ between the synovial fluid of healthy individuals and individuals with RA. Thus, patients with RA have synovial inflammation despite normal levels of Treg cells.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“This paradox triggered our interest and prompted us to investigate the underlying mechanism. We later discovered that synovial Treg cells had no regulatory function and that there was a posttranslational defect in FOXP3 (FOXP3 was not properly phosphorylated),” explained Jingwu Z. Zhang, also of the Shanghai Jiao Tong University School of Medicine, by e-mail.

The authors found that TNF-α induces FOXP3 dephosphorylation, thereby controlling the balance of Treg cells and pathogenic Th17 and Th1 cells. The improper phosphorylation of FOXP3 translates into severely impaired regulatory function.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thus, aberrant TNF-α production in the synovium drives a pathological circuit by inducing macrophage-produced protein phosphatase 1 (PP1). PP1 then dephosphorylates the Ser418 phosphorylation site of the FOXP3 in Treg cells.

When the authors treated patients with RA with TNF-α–specific antibody, they were able to restore Treg cell function. They also found an associated decrease in PP1 expression and increased FOXP3 phosphorylation in Treg cells.

“This post translational defect of FOXP3/Treg cells can be corrected by giving TNF-α blockers. The conclusion of the study provides a powerful mechanistic explanation as to why TNF-α works in RA as a disease-modifying treatment,” wrote Dr. Zhang.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Many inflammatory diseases have impaired Treg cells. It may be that FOXP3 and other transcription factors are influenced and/or impaired by the local proinflammatory cytokine milieu. The transcription factors may be modified at a posttranslational or epigenetic level by the cytokines explained Dr. Zhang.

These results add to previous studies that have demonstrated that protein kinase C-θ (PKC-θ) mediates the inhibitory effects of TNF-α on Treg cells.


Dr. Pullen is a medical writer based in the Chicago area.

Reference

  1. Nie H, Zheng Y, Li R, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med. 2013;19:322-328.

     

Pages: 1 2 | Multi-Page

Filed Under: Safety Tagged With: Rheumatoid arthritis, T-cells, TNF

You Might Also Like:
  • Adalimumab Drives Regulatory T Cell Expansion by Binding to Membrane TNF
  • 2014 ACR/ARHP Annual Meeting: Regulatory T Cells
  • Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis
  • Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.